E. Dotor
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
Papers in
- Oncology 17
- Colorectal Cancer Treatments and Studies 11
- Colorectal Cancer Surgical Treatments 4
- Cancer Treatment and Pharmacology 3
- Pancreatic and Hepatic Oncology Research 2
-
- Gastric Cancer Management and Outcomes 4
- Renal cell carcinoma treatment 2
- Co-authors
- Carles Pericay (6 shared papers)Eugeni Saigí (5 shared papers)Xavier Serra‐Aracil (2 shared papers)Álex Casalots (2 shared papers)Anna Ruiz (1 shared paper)Matilde Navarro (3 shared papers)Anna Ferrer (1 shared paper)Enrique Aranda (8 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Clinical & Translational Oncology (4 papers)Frontiers in Genetics (1 paper)Critical Reviews in Oncology/Hematology (1 paper)The Oncologist (1 paper)
- Partner nations
- SpainUnited KingdomFrance
In The Last Decade
E. Dotor
23 papers receiving 469 citations
Peers
Comparison fields: 5 of 43
- Cancer Research 138
- Oncology 240
- Geriatrics and Gerontology 16
- Pathology and Forensic Medicine 47
- Molecular Biology 136
Countries citing papers authored by E. Dotor
This map shows the geographic impact of E. Dotor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Dotor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Dotor more than expected).
Fields of papers citing papers by E. Dotor
This network shows the impact of papers produced by E. Dotor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Dotor. The network helps show where E. Dotor may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Dotor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 146 | |
| 2 | 2006 | 101 | |
| 3 | 2006 | 56 | |
| 4 | 2015 | 36 | |
| 5 | 2016 | 24 | |
| 6 | 2018 | 22 | |
| 7 | 2007 | 20 | |
| 8 | 2019 | 12 | |
| 9 | 2009 | 11 | |
| 10 | 2013 | 10 | |
| 11 | 2015 | 9 | |
| 12 | 2004 | 6 | |
| 13 | 2016 | 5 | |
| 14 | 2016 | 4 | |
| 15 | 2011 | 3 | |
| 16 | 2014 | 3 | |
| 17 | 2014 | 1 | |
| 18 | 2004 | 1 | |
| 19 | 2004 | 1 | |
| 20 | 2016 | 1 |
About E. Dotor
E. Dotor is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Molecular Biology, having authored 23 papers that have together received 475 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (11 papers), Colorectal Cancer Surgical Treatments (4 papers), Gastric Cancer Management and Outcomes (4 papers), Colorectal and Anal Carcinomas (3 papers), Cancer Treatment and Pharmacology (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer Genomics and Diagnostics (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Cancer Research (138 citations), Oncology (240 citations), Geriatrics and Gerontology (16 citations), Pathology and Forensic Medicine (47 citations) and Molecular Biology (136 citations). E. Dotor has collaborated with scholars based in Spain, United Kingdom and France. Frequent co-authors include Carles Pericay, Eugeni Saigí, Xavier Serra‐Aracil, Álex Casalots, Anna Ruiz, Matilde Navarro, Anna Ferrer, Enrique Aranda, Fernando Rivera and Josep R. Germà. Their work appears in journals such as Journal of Clinical Oncology, Clinical & Translational Oncology, Frontiers in Genetics, Critical Reviews in Oncology/Hematology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.